Corporate News     08-Feb-24
Board of Aarti Pharmalabs recommends interim dividend
Of Rs 2 per share
Aarti Pharmalabs announced that the Board of Directors of the Company at its meeting held on 7 February 2024, inter alia, have recommended the interim dividend of Rs 2 per equity Share (i.e. 40%) , subject to the approval of the shareholders.
Previous News
  Aarti Pharmalabs consolidated net profit rises 17.75% in the June 2024 quarter
 ( Results - Announcements 05-Aug-24   16:23 )
  Aarti Pharmalabs to discuss results
 ( Corporate News - 03-May-23   13:50 )
  Aarti Pharmalabs jumps after Q4 PAT climbs 52% YoY to Rs 65 cr
 ( Hot Pursuit - 14-May-24   09:43 )
  Aarti Pharmalabs receives ratings for LT bank facilities
 ( Corporate News - 04-Mar-23   11:18 )
  CRISIL reaffirms ratings of Aarti Pharmalabs with 'positive' outlook
 ( Hot Pursuit - 27-Jun-24   13:54 )
  Aarti Pharmalabs announces board meeting date
 ( Corporate News - 01-Feb-24   12:47 )
  Aarti Pharmalabs consolidated net profit rises 52.20% in the March 2024 quarter
 ( Results - Announcements 14-May-24   07:33 )
  Aarti Pharmalabs to declare Quarterly Result
 ( Corporate News - 29-Jul-23   17:21 )
  Board of Aarti Pharmalabs recommends Final Dividend
 ( Corporate News - 13-May-24   17:30 )
  Aarti Pharmalabs consolidated net profit rises 1.39% in the September 2023 quarter
 ( Results - Announcements 08-Nov-23   07:42 )
  Aarti Pharmalabs consolidated net profit declines 9.16% in the June 2023 quarter
 ( Results - Announcements 05-Aug-23   17:00 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top